SALIVARY IL-6 AND IL-8 AS POTENTIAL BIOMARKERS FOR ORAL SQUAMOUS CELL CARCINOMA

Fitrah Utari Bakti, Riani Setiadhi

Abstract


Introduction: Early identification of oral squamous cell carcinoma (OSCC) is a crucial factor influencing the disease's prognosis. The elevated levels of IL-6 and IL-8 in saliva are a result of their overproduction in the cancer microenvironment. The production of salivary cytokines, particularly IL-6 and IL-8, has a role in cancer development. These cytokines may also be used as biomarkers. The use of saliva as a biomarker is quite interesting because it is in direct contact with cancer cells, easy to access, non-invasive, and cost-effective. Aim: The aim of this literature review was to assess the potential of salivary IL-6 and IL-8 as biomarkers for OSCC early diagnosis. Review: The initiation of carcinogenesis in the oral cavity is actively repressed by inflammation and cell-mediated immunity. IL-6 and IL-8 are two important molecules involved in stromal-to-cancer cell communication. These cytokines play a major part in the growth, progression, metastasis, and recurrence of OSCC. Several studies have found that OSCC patients have higher levels of salivary IL-6 and IL-8 than healthy people and patients with an oral potentially malignant disorder (OPMD). Conclusion: Salivary IL-6 and IL-8 are very promising potential biomarkers for the early diagnosis of OSCC. Further research is still needed to validate and use these biomarkers clinically.


Keywords


Cytokines, interleukin-6, interleukin-8, oscc, saliva

Full Text:

PDF

References


Dolens E da S, Dourado MR, Almangush A, Salo TA, Gurgel Rocha CA, da Silva SD, et al. The Impact of Histopathological Features on the Prognosis of Oral Squamous Cell Carcinoma: A Comprehensive Review and Meta-Analysis. Front Oncol. 2021;11(November):1–13.

Rai AK, Panda M, Das AK, Rahman T, Das R, Das K, et al. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation. Arch Microbiol. 2021;203(1):137–52.

Rezaei F, Mozaffari HR, Tavasoli J, Zavattaro E, Imani MM, Sadeghi M. Evaluation of Serum and Salivary Interleukin-6 and Interleukin-8 Levels in Oral Squamous Cell Carcinoma Patients: Systematic Review and Meta-Analysis. Journal of Interferon and Cytokine Research. 2019;39(12):727–39.

Blatt S, Krüger M, Ziebart T, Sagheb K, Schiegnitz E, Goetze E, et al. Biomarkers in diagnosis and therapy of oral squamous cell carcinoma: A review of the literature. Journal of Cranio-Maxillofacial Surgery. 2017;45(5):722–30.

Roi A, Roi CI, Negruțiu ML, Riviș M, Sinescu C, Rusu LC. The challenges of OSCC diagnosis: Salivary cytokines as potential biomarkers. J Clin Med. 2020;9(9):1–16.

Nguyen TTH, Sodnom-Ish B, Choi SW, Jung H Il, Cho J, Hwang I, et al. Salivary biomarkers in oral squamous cell carcinoma. J Korean Assoc Oral Maxillofac Surg. 2020;46(5):301–12.

Cristaldi M, Mauceri R, Di Fede O, Giuliana G, Campisi G, Panzarella V. Salivary biomarkers for oral squamous cell carcinoma diagnosis and follow-up: Current status and perspectives. Front Psychol. 2019;10(December):1–12.

Sahibzada HA, Khurshid Z, Khan RS, Naseem M, Siddique KM, Mali M, et al. Salivary IL-8, IL-6 and TNF-α as Potential Diagnostic Biomarkers for Oral Cancer. Diagnostics. 2017;7(2):21.

Thomson PJ. Perspectives on oral squamous cell carcinoma prevention—proliferation, position, progression and prediction. Journal of Oral Pathology and Medicine. 2018;47(9):803–7.

Ferrari E, Pezzi ME, Cassi D, Pertinhez TA, Spisni A, Meleti M. Salivary cytokines as biomarkers for oral squamous cell carcinoma: A systematic review. Int J Mol Sci. 2021;22(13).

Chiamulera MMA, Zancan CB, Remor AP. Salivary cytokines as biomarkers for oral squamous cell carcinoma: A systematic review. BMC Cancer. 2021;21(205):1–16.

Kaur J, Preethi M, Srivastava R, Borse V. Role of IL-6 and IL-8 biomarkers for optical and electrochemical based point-of-care detection of oral cancer. Biosens Bioelectron X. 2022;11(August):100212.

Melguizo-Rodríguez L, Costela-Ruiz VJ, Manzano-Moreno FJ, Ruiz C, Illescas-Montes R. Salivary biomarkers and their application in the diagnosis and monitoring of the most common oral pathologies. Int J Mol Sci. 2020;21(14):1–17.

Rezaei F, Mozaffari HR, Tavasoli J, Zavattaro E, Imani MM, Sadeghi M. Evaluation of Serum and Salivary Interleukin-6 and Interleukin-8 Levels in Oral Squamous Cell Carcinoma Patients: Systematic Review and Meta-Analysis. Journal of Interferon and Cytokine Research. 2019;39(12):727–39.

Ettinger KS, Ganry L, Fernandes RP. Oral Cavity Cancer. Oral and Maxillofacial Surgery Clinics of North America. 2019;31(1):13–29.

Principe S, Zapater-Latorre E, Arribas L, Garcia-Miragall E, Bagan J. Salivary IL-8 as a putative predictive biomarker of radiotherapy response in head and neck cancer patients. Clinical Oral Investigations. 2022;26(1):437–48.

Farooq I, Bugshan A. Oral squamous cell carcinoma: Metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis. F1000Research. 2020;9:1–10.

Lin NC, Hsien SI, Hsu JT, Chen MYC. Impact on patients with oral squamous cell carcinoma in different anatomical subsites: a single-center study in Taiwan. Scientific Reports. 2021;11(1):1–9.

Almangush A, Mäkitie AA, Triantafyllou A, de Bree R, Strojan P, Rinaldo A, et al. Staging and grading of oral squamous cell carcinoma: An update. Oral Oncology. 2020;107(May):104799.

Tampa M, Mitran MI, Mitran CI, Sarbu MI, Matei C, Nicolae I, et al. Mediators of inflammation – A potential source of biomarkers in oral squamous cell carcinoma. Journal of Immunology Research. 2018;2018.

Zou Z, Li B, Wen S, Lin D, Hu Q, Wang Z, et al. The Current Landscape of Oral Squamous Cell Carcinoma: A Comprehensive Analysis from ClinicalTrials.gov. Cancer Control. 2022;29:1–14.

Lu C, Lewis JS, Dupont WD, Plummer WD, Janowczyk A, Madabhushi A. An oral cavity squamous cell carcinoma quantitative histomorphometric-based image classifier of nuclear morphology can risk stratify patients for disease-specific survival. Modern Pathology. 2017;30(12):1655–65.

Lee LT, Wong YK, Hsiao HY, Wang YW, Chan MY, Chang KW. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery. 2018;47(6):699–707.

Hussein AA, Forouzanfar T, Bloemena E, de Visscher J, Brakenhoff RH, Leemans CR, et al. A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma. British Journal of Cancer. 2018;119(6):724–36.




DOI: https://doi.org/10.33854/jbd.v10i2.1460

DOI (PDF): https://doi.org/10.33854/jbd.v10i2.1460.g515

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Fitrah Utari Bakti

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.